What We Do
About Us
FAQ
Insights
Contact Us
What We Do
About Us
FAQ
Insights
Contact Us
Insights
Some of our public alerts on emerging trends…
Skin cancer risk from ED drugs cited in plaintiffs’ firm ads
the215guys
09 August, 2017
Pradaxa Reemerges as Top Mass Tort Ad Target
the215guys
09 August, 2017
Zofran Ad Surge Signals Heightened Litigation Interest
the215guys
09 August, 2017
Infuse Bone Graft Ads Jump in January
the215guys
09 August, 2017
NY Political Scandal Highlights Competition for Asbestos Cases
the215guys
09 August, 2017
Amidst Auto Recalls, Law Firms Launch Airbag Defect Ad Campaigns
the215guys
09 August, 2017
Sign up to receive our alerts on new developments:
Tags
AbbVie
Alternative Litigation Financing
AndroGel
Asbestos
Axiron
Bayer
Bloomberg
Boehringer Ingelheim
BP
Cash Advances
CW
Davis & Crump
Dialysis
Eli Lily
Environmental Contamination
FDA Safety Advisory
Fracking
Fresenius Medical Center
Goa Honnold
Granuflo
Gulf of Mexico Oil Spill
Hemodialysis
Hydraulic Fracturing
Institute for Legal Reform
Janssen Pharmaceuticals
Jo
Johnson & Johnson
Lilly
Low T
Mesothelioma
Meyer Blair
NBC
Pelvic Mesh
Peter Angelos
Pradaxa
Pulaski & Middleman
Renal Failure
Riata Defibrillator
Risperdal
Simien & Simien
St. Jude Medical
Structured Settlements
Testosteron Therapy
WGN
Xarelto
